18
Japanese MedTech company Terumo Medical Corporation, a subsidiary of Terumo Corporation, has announced the US launch of its SurTract Safety Syringe, powered by SafeR passive safety technology. Developed by Roncadelle Operations S.r.l, the SurTract Syringe will be distributed across hospitals, clinics, and emergency-care settings beginning in the first quarter of 2026.
SafeR technology provides the SurTract Syringe with a fully passive, automatic retraction mechanism that withdraws the needle into the plunger immediately after use, which the company says helps to reduce the risk of needle-stick injuries for physicians, and providing patients with a smooth and comfortable injection due to less plunger pressure.
“The…